IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v459y2009i7250d10.1038_nature08109.html
   My bibliography  Save this article

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer

Author

Listed:
  • Kenneth L. Scott

    (Department of Medical Oncology,)

  • Omar Kabbarah

    (Department of Medical Oncology,)

  • Mei-Chih Liang

    (Department of Medical Oncology,
    Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, Massachusetts 02115, USA)

  • Elena Ivanova

    (Belfer Institute for Applied Cancer Science,)

  • Valsamo Anagnostou

    (Yale University School of Medicine, New Haven, Connecticut 06520, USA)

  • Joyce Wu

    (Department of Medical Oncology,)

  • Sabin Dhakal

    (Department of Medical Oncology,)

  • Min Wu

    (Department of Medical Oncology,)

  • Shujuan Chen

    (Department of Medical Oncology,)

  • Tamar Feinberg

    (Department of Medical Oncology,)

  • Joseph Huang

    (Department of Medical Oncology,)

  • Abdel Saci

    (Harvard Medical School)

  • Hans R. Widlund

    (Dana-Farber Cancer Institute
    Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA)

  • David E. Fisher

    (Dana-Farber Cancer Institute
    Massachusetts General Hospital, Boston, Massachusetts 02114, USA)

  • Yonghong Xiao

    (Belfer Institute for Applied Cancer Science,)

  • David L. Rimm

    (Yale University School of Medicine, New Haven, Connecticut 06520, USA)

  • Alexei Protopopov

    (Belfer Institute for Applied Cancer Science,)

  • Kwok-Kin Wong

    (Department of Medical Oncology,
    Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, Massachusetts 02115, USA)

  • Lynda Chin

    (Department of Medical Oncology,
    Belfer Institute for Applied Cancer Science,
    Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA)

Abstract

Genome-wide copy number analyses of human cancers identified a frequent 5p13 amplification in several solid tumour types, including lung (56%), ovarian (38%), breast (32%), prostate (37%) and melanoma (32%). Here, using integrative analysis of a genomic profile of the region, we identify a Golgi protein, GOLPH3, as a candidate targeted for amplification. Gain- and loss-of-function studies in vitro and in vivo validated GOLPH3 as a potent oncogene. Physically, GOLPH3 localizes to the trans-Golgi network and interacts with components of the retromer complex, which in yeast has been linked to target of rapamycin (TOR) signalling. Mechanistically, GOLPH3 regulates cell size, enhances growth-factor-induced mTOR (also known as FRAP1) signalling in human cancer cells, and alters the response to an mTOR inhibitor in vivo. Thus, genomic and genetic, biological, functional and biochemical data in yeast and humans establishes GOLPH3 as a new oncogene that is commonly targeted for amplification in human cancer, and is capable of modulating the response to rapamycin, a cancer drug in clinical use.

Suggested Citation

  • Kenneth L. Scott & Omar Kabbarah & Mei-Chih Liang & Elena Ivanova & Valsamo Anagnostou & Joyce Wu & Sabin Dhakal & Min Wu & Shujuan Chen & Tamar Feinberg & Joseph Huang & Abdel Saci & Hans R. Widlund , 2009. "GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer," Nature, Nature, vol. 459(7250), pages 1085-1090, June.
    • Handle: RePEc:nat:nature:v:459:y:2009:i:7250:d:10.1038_nature08109
    DOI: 10.1038/nature08109
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature08109
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature08109?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:459:y:2009:i:7250:d:10.1038_nature08109. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.